Profile picture

Associate Professor Masanari Kuwabara

Jichi Medical University, Shimotsuke (Japan)
Membership: FESC Member
Follow
Biography
Masanari Kuwabara is currently an Associate Professor in Jichi Medical University, Shimotuke, Tochigi, Japan. He graduated from Tottori University Medical School and received M.D. in 2007. He also received Ph.D. (Regenerative Medicine) from Tottori University Graduate School of Medical Science (Prof. Ichiro Hisatome) in 2014 and Ph.D. (Medicine, Epidemiology) from Jichi Medical University (Prof. Yosikazu Nakamura) in 2017. He finished postdoctoral fellowship at the University of Colorado Denver (Prof. Richard J. Johnson) in 2018. His expertise is in the field of cardiovascular prevention, especially uric acid and cardiovascular diseases, including hypertension, dyslipidemia, diabetes mellitus, metabolic syndrome, kidney diseases, and heart failure. He has received more than 20 awards from various academic societies and published more than 160 articles (impact factor over 1,000, H-index 50, Citations 10,000 (Google scholar)).
Logo ESC

Contributor content

Dynamic interplay of body mass index and hypertension: a 10-year longitudinal study revealing cumulative risk
Presentation
Dynamic interplay of body mass index and hypertension: a 10-year longitudinal study revealing cumulative risk
Xanthine oxidase inhibitors in cardiovascular disease: impact on mortality and ATP dynamics
Presentation
Xanthine oxidase inhibitors in cardiovascular disease: impact on mortality and ATP dynamics
Xanthine oxidase inhibitors withdrawal syndrome
Presentation
Xanthine oxidase inhibitors withdrawal syndrome
Mortality and characteristics among four DOACs and warfarin.
Presentation
Mortality and characteristics among four DOACs and warfarin.
Hyperfiltration could be a risk factor for development of hypertension: A five-year cohort study
Presentation
Hyperfiltration could be a risk factor for development of hypertension: A five-year cohort study
Optimal serum uric acid levels for hypertension:5-year cohort study
Presentation
Optimal serum uric acid levels for hypertension:5-year cohort study
The effect of early intravenous immunoglobulin therapy for Kawasaki disease: 22nd nationwide survey in Japan
Presentation
The effect of early intravenous immunoglobulin therapy for Kawasaki disease: 22nd nationwide survey in Japan
Obesity and serum uric acid as a risk factor for hypertension and diabetes mellitus: 5-year Japanese cohort study
Presentation
Obesity and serum uric acid as a risk factor for hypertension and diabetes mellitus: 5-year Japanese cohort study

ESC 365 is supported by